Results 41 to 50 of about 114,322 (384)

The potential for deprescribing in care home residents with Type 2 diabetes [PDF]

, 2016
Background: Type 2 diabetes is a common diagnosis in care home residents that is associated with potentially inappropriate prescribing and thus risk of additional suffering.
Andreassen, Lillan Mo, Desborough, James Antony, Houghton, Julie, Kjome, Reidun Lisbet Skeide, Sølvik, Una Ørvim   +4 more
core   +1 more source

Factors associated with polypharmacy and the high risk of medication-related problems among older community-dwelling adults in European countries: a longitudinal study

BMC Geriatrics, 2022
Background Polypharmacy can be defined as using five or more medications simultaneously. “Medication-related problems”, an extension of polypharmacy, includes inappropriate prescribing, poor adherence, overdosage, underdosage, inappropriate drug ...
L. Ye, Junwen Yang-Huang, C. Franse, T. Rukavina, V. Vasiljev, F. Mattace-Raso, A. Verma, T. A. Borrás, T. Rentoumis, H. Raat   +9 more
semanticscholar   +1 more source

Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study

BMJ Open, 2016
Objectives (1) To evaluate the prevalence of polypharmacy (5–9 medicines) and excessive polypharmacy (10+ medicines) and (2) to determine associated demographic and clinical characteristics in an ageing population with intellectual disabilities (IDs ...
Mary McCarron, Philip McCallion, Máire O'Dwyer, Jure Peklar, Martin C Henman   +4 more
doaj   +1 more source

Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial [PDF]

, 2016
In 2010 the 'Polymedication Check' (PMC), a pharmacist-led medication review, was newly introduced to be delivered independently from the prescriber and reimbursed by the Swiss health insurances.
Blozik, Eva, Hersberger, Kurt E., Messerli, Markus, Vriends, Noortje   +3 more
core   +3 more sources

Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study [PDF]

Intestinal Research, 2019
Background/Aims Polypharmacy is a common clinical problem with chronic diseases that can be associated with adverse patient outcomes. The present study aimed to determine the prevalence and patient-specific characteristics associated with polypharmacy in
Jingzhou Wang, Takahiro I Nakamura, Anne G Tuskey, Brian W Behm   +3 more
doaj   +1 more source

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

European Heart Journal - Cardiovascular Pharmacotherapy, 2022
Population ageing has resulted in an increasing number of older people living with chronic diseases (multimorbidity) requiring five or more medications daily (polypharmacy).
J. Tamargo, K. P. Kjeldsen, E. Delpón, A. Semb, E. Cerbai, D. Dobrev, G. Savarese, P. Sulzgruber, G. Rosano, C. Borghi, S. Wassman, C. Torp-Pedersen, S. Agewall, H. Drexel, I. Baumgartner, B. Lewis, C. Ceconi, J. Kaski, A. Niessner   +18 more
semanticscholar   +1 more source

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Polypharmacy is highly prevalent in elderly people with chronic conditions, including atrial fibrillation (AF). The impact of polypharmacy on adverse outcomes and on treatment effectiveness in elderly patients with AF remains unaddressed ...
Nemin Chen, Aniqa B. Alam, Pamela L. Lutsey, Richard F. MacLehose, J'Neka S. Claxton, Lin Y. Chen, Alanna M. Chamberlain, Alvaro Alonso   +7 more
doaj   +1 more source

Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens

Frontiers in Pharmacology, 2021
Introduction: Polypharmacy is a risk factor for adverse health outcomes, higher use of medical services and additional costs. The problem has gained attention as a consequence of aging and related multimorbidity.
Przemysław Kardas, Filip Urbański, Aneta Lichwierowicz, Ewa Chudzyńska, Grzegorz Kardas, Marcin Czech   +5 more
doaj   +1 more source

Prevalence of drug-herb and drug-supplement interactions in older adults : A cross-sectional survey [PDF]

, 2018
© British Journal of General PracticeBackground Polypharmacy is common among older adults, with increasing numbers also using prescription drugs with herbal medicinal products (HMPs) and dietary supplements.
Agbabiaka, Alsanad, Arcury, Batanero-Hernán, Blalock, Claire Goodman, Djuv, Farina, Ginter, Gonzàlez-Stuart, Ly, McLay, Neil H Spencer, Peklar, Porqueddu, Qato, Sabina Khanom, Schnabel, Steyn, Taofikat B Agbabiaka   +19 more
core   +2 more sources

Polypharmacy and the coproduction of the experience between physicians and patients

Teoria e Prática em Administração, 2021
Purpose: To identify how physicians can help polypharmacy patients deal with their disease condition by focusing on the non-clinical factors of care processes.
Md Mafuzul Huq, Julie Maryne Fingolo, Claudia Araujo   +2 more
doaj   +1 more source